Simris Alg AB Class B (SIMRIS.B) AI Stock Analysis

• Market Cap: kr125.53M
• Dividend Yield: N/A
• Average Volume (3M): 223.88K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.23
• Revenue Growth: -49.72%
• EPS Growth: 36.20%
• Country: SE
• Employees: 7
• Sector: Healthcare
• Sector Strength: 45
• Industry: Biotechnology
• EPS (TTM): >-0.01
• Shares Outstanding: 1,349,793,200
• 10 Day Avg. Volume: 120,731
• 30 Day Avg. Volume: 223,875
• PEG Ratio: 0.02
• Price to Book (P/B): -76.69
• Price to Sales (P/S): 22.32
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 43 Neutral
• Price Target: kr0.09 ▲(125.00% Upside)
• Action: Upgraded Date: 03/02/26
• Date: Action: Upgraded 03/02/26

The score is weighed down primarily by very weak financial performance (shrinking revenue, heavy losses, ongoing cash burn, and deteriorating balance sheet with negative equity and higher debt). Technicals are mixed and only mildly supportive, while valuation offers limited comfort due to negative earnings and no dividend yield.

Positive Factors

Vertical integration (cultivation to commercialization)

Owning cultivation, processing and commercialization creates durable control over supply, quality and IP. Vertical integration can protect margins, shorten supply chains and enable iterative process improvements that support scalable production and product consistency over months.

Product differentiation and sustainable omega-3 focus

A focus on algae-derived omega-3 targets structural demand for sustainable, non-fish omega-3s in nutraceuticals and food ingredients. This differentiated product positioning supports long-term niche pricing power and regulatory/consumer tailwinds that remain relevant over the medium term.

Prior positive gross profit periods

Positive gross profit in 2023–2024 indicates the business can achieve product-level economics under certain conditions. That history implies operational levers exist—pricing, yields or cost control—that could be re-applied to restore unit economics if scale or process improvements are executed.

Negative Factors

Deteriorated balance sheet and negative equity

Equity turning slightly negative and a sharp rise in debt materially reduce financial flexibility. Negative equity and higher leverage raise refinancing and solvency risk, constrain investment capacity, and increase the likelihood of dilutive or restrictive financing over the coming months.

Persistent negative operating cash flow

Consistently negative operating cash flow means the core business is not self-funding and requires continual external capital. That cash-burn profile heightens reliance on financing, limits runway for commercialization or scaling, and represents a sustained solvency risk if capital markets tighten.

Shrinking revenue and worsening profitability

Sharp, consecutive revenue declines with recurring large operating losses indicate weakening demand or execution. Declining top-line impairs absorption of fixed costs, degrades operating leverage and makes returning to sustainable profitability more difficult without structural changes.

Simris Alg AB Class B Business Overview & Revenue Model

Company Description

Simris Alg AB (publ) manufactures and sells dietary supplements and algae-based foods in Sweden and internationally. It offers Simris Algae Omega-3, a plant-based marine omega-3 EPA and DHA line; and a line of algae-based products, such as finest chlorella, spirulina sprinkles, boosting astaxanthin, flower power algae tea, and sun candy algae tea under the Simris Select brand. The company was founded in 2010 and is headquartered in Hammenhög, Sweden.

How the Company Makes Money

null

Simris Alg AB Class B Financial Statement Overview

Summary

Financials indicate very high risk: revenues are small and declining sharply, losses are persistent and deep, operating cash flow remains materially negative, and 2025 shows a step-change in financial stress with equity turning slightly negative alongside a sharp rise in debt.

Income Statement

The income statement remains very weak. Revenue is small and declining (down ~34% in 2024 and ~37% in 2025), while profitability is deeply negative with recurring large operating losses and net losses each year. Gross profit was positive in 2023–2024 but swung sharply negative in 2025, indicating deteriorating unit economics and limited operating leverage despite years of operations.

Balance Sheet

The balance sheet has deteriorated materially. Equity fell from positive levels in prior years to slightly negative in 2025, which reduces financial flexibility and signals accumulated losses have eroded the capital base. At the same time, total debt jumped dramatically in 2025, creating a highly leveraged profile versus an asset base that has not translated into earnings, raising refinancing and solvency risk.

Cash Flow

Cash flow quality is weak and consistently negative. Operating cash flow has been materially negative every year shown, indicating the core business is not self-funding. Free cash flow is also negative when reported (2020–2024) and the 2025 free cash flow value appears as zero, suggesting either a reporting gap or a sharp change that is not corroborated by still-negative operating cash flow; overall, liquidity burn remains a key concern.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.61M	2.89M	4.35M	4.08M	6.14M
Gross Profit	-31.34M	1.22M	2.01M	-742.00K	-2.07M
EBITDA	-17.32M	-17.59M	-22.36M	-18.00M	-24.81M
Net Income	-26.81M	-34.60M	-37.30M	-24.42M	-28.36M
Balance Sheet
Total Assets	148.38M	157.06M	174.55M	185.71M	29.20M
Cash, Cash Equivalents and Short-Term Investments	1.47M	1.95M	5.67M	3.99M	961.00K
Total Debt	87.68M	2.04M	2.67M	2.13M	3.13M
Total Liabilities	148.85M	151.42M	148.94M	162.68M	10.98M
Stockholders Equity	-470.00K	5.64M	25.61M	23.03M	18.22M
Cash Flow
Free Cash Flow	0.00	-18.63M	-37.96M	-40.57M	-18.39M
Operating Cash Flow	-16.05M	-18.02M	-36.35M	-18.19M	-18.14M
Investing Cash Flow	-224.00K	-613.00K	-1.61M	-22.38M	-253.00K
Financing Cash Flow	15.79M	14.91M	39.63M	43.60M	2.84M

Simris Alg AB Class B Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.04
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SIMRIS.B, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.10, below the 50-day MA of 0.09, and below the 200-day MA of 0.12, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 47.42 is Neutral, neither overbought nor oversold. The STOCH value of 20.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:SIMRIS.B.

Simris Alg AB Class B Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
ONCOZ	47 Neutral	kr79.51M	-5.14	-202.18%	―	―	20.55%
PILA	44 Neutral	kr57.10M	―	-601.02%	―	―	―
SIMRIS.B	43 Neutral	kr125.53M	-1.34	―	―	-49.72%	36.20%
MODTX	43 Neutral	kr35.15M	-1.03	-457.91%	―	―	-19.35%
EXPRS2	43 Neutral	kr17.76M	-1.19	-88.65%	―	8.46%	11.73%
LPGO	41 Neutral	kr4.85M	-3.06	-213.85%	―	―	―